Pacific Biosciences of California, Inc. is a life science technology company. It is engaged in designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to resolve genetically complex problems. Its products and technology under development stem from two differentiated core technologies, which include its HiFi long-read sequencing technology and its Sequencing by Binding (SBB) short-read sequencing technology. Its products address solutions across a set of applications, including human genetics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. It has developed HiFi long-read sequencing based on Single-Molecule Real-Time technology, which accurately detects the nucleotide sequence and epigenetic status of individual DNA molecules. Its Revio, Sequel, Sequel II and Sequel IIe instruments conduct, monitor, and analyze single-molecule biochemical reactions in real time.
BörsenkürzelPACB
Name des UnternehmensPacific Biosciences of California Inc
IPO-datumOct 27, 2010
CEOMr. Christian O. Henry
Anzahl der mitarbeiter575
WertpapierartOrdinary Share
GeschäftsjahresendeOct 27
Addresse1305 O'brien Drive
StadtMENLO PARK
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl94025
Telefon16505218000
Websitehttps://www.pacb.com/
BörsenkürzelPACB
IPO-datumOct 27, 2010
CEOMr. Christian O. Henry
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten